Riskpilot← Back to searchSign inGet full accessAMA-Pharma AB
ABActiveOrg 5569030652Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20120 employees
Revenue 2024
SEK 0
EBITDA margin
—
+12% vs 2023
Equity ratio
96.7%
Financial strength
Net profit 2024
SEK -22K
+12% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -22K | +12% |
| Net profit | SEK -22K | +12% |
| Total assets | SEK 600K | -4% |
| Equity | SEK 580K | -4% |
| Employees | 0 | — |
Legal name
AMA-Pharma AB
Org number
5569030652
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
6 september 2012
Share capital
SEK 75 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att förvalta aktier i bolag som bedriver apoteksverksamhet samt att, direkt eller indirekt, äga och förvalta övrig fast och lös egendom och därmed förenlig verksamhet.
Address
Email
matti.yacob@apoteksgruppen.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −24 | −346 | −441 | −119 | −28 | −21 | −23 | −23 | −25 | −22 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | −0 |
| EBIT | −24 | −346 | −441 | −119 | −28 | −21 | −23 | −23 | −25 | −22 |
| Net financials | −12 | −7 | 5 207 | 21 | −194 | 231 | −38 | 27 | — | — |
| Profit before tax | −37 | −352 | 4 767 | −98 | −222 | 210 | −61 | — | −25 | −22 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — | −0 | −0 |
| Net profit | −37 | −352 | 4 767 | −98 | −222 | 210 | −61 | 4 | −25 | −22 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 227 | 2 224 | 6 149 | 712 | 491 | 703 | 643 | 648 | 623 | 600 |
| Equity | 984 | 632 | 4 844 | 696 | 474 | 684 | 623 | 627 | 603 | 580 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 |
| Short-term debt | 243 | 1 592 | 1 305 | 16 | 17 | 19 | 20 | 21 | 20 | 20 |
| Total debt | 243 | 1 592 | 1 305 | 16 | 17 | 19 | 20 | 21 | 20 | 20 |
EBITDA margin
-2200000.0%
This company
15.8%
Market median
-13924151% vs market
20152024
Equity ratio
96.7%
This company
38.2%
Market median
+153% vs market
20152024
Return on equity
-3.8%
This company
18.4%
Market median
-121% vs market
20152024
Net profit margin
-2200000.0%
This company
8.1%
Market median
-27160594% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ME Chief Auditor | Chief Auditor | 2025 | — | — |
AK Chief Auditor | Chief Auditor | 2020 | — | — |
JL Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AMA-Pharma AB 
Apoteksgruppen i Rotebro Nr 2 ABBoard members of AMA-Pharma AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Elisabeth Terneblad | Chief Auditor | 0 companies |
| A Kornelia B Wall Andersson | Chief Auditor | 0 companies |
| Jonas Lars Lindgren | Chief Auditor | 0 companies |
| Asaad Abdulsalam Khaleel Al Zubaydi | Chairman | 0 companies |
| Maysaloon Khalaf Abbas | Deputy Board Member | 0 companies |
| Matti Yousef Yacob | Board of Directors | 0 companies |
| Ahmed Munir Abdulhamed | Board of Directors | 0 companies |
| Maysaloon Khalaf Abbas | Deputy Board Member | 0 companies |